Eyewire Today http://eyewiretoday.com/ Eyewire Today en-us Sat, 29 Apr 2017 07:33:11 GMT Sat, 29 Apr 2017 07:33:11 GMT EyewireToday.com AAN 2017 Meeting: Racial and Regional Disparities Identified Endovascular Care Delivery http://eyewiretoday.com/view.asp?url=aan-2017-meeting-racial-and-regional-disparities-identified-endovascular-care-delivery Access to endovascular care is significantly impacted by factors such as race, region, and hospital, according to findings presented this week at the American Academy of Neurology (AAN) Annual Meeting in Boston. Investigators analyzed data from a lar... Fri, 28 Apr 2017 04:00:00 GMT AAN 2017 Meeting: New Evidence Suggest Parkinson’s Originates in the Gut http://eyewiretoday.com/view.asp?url=aan-2017-meeting-new-evidence-suggest-parkinsons-originates-in-the-gut Parkinson’s disease may start in the gut and spread to the brain via the vagus nerve, according to a study published in the April 26, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. When researche... Wed, 26 Apr 2017 04:00:00 GMT AAN 2017 Meeting: New Data Reinforce Efficacy of Ocrelizumab http://eyewiretoday.com/view.asp?url=aan-2017-new-data-reinforce-efficacy-of-ocrelizumab New data presented at the American Academy of Neurology (AAN) Annual Meeting in Boston show the benefits of ocrelizumab in relapsing multiple sclerosis (MS). In a pooled analysis of Phase 3 OPERA studies, ocrelizumab reduced the relapse rate by 55 pe... Wed, 26 Apr 2017 04:00:00 GMT AAN Unveils New Guideline for SUDEP at Annual Meeting http://eyewiretoday.com/view.asp?url=aan-unveils-new-guideline-for-sudep-at-annual-meeting The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have released a new joint guideline for sudden unexpected death in epilepsy (SUDEP) at the AAN Annual Meeting in Boston. SUDEP is rare in children, affecting just one in ... Tue, 25 Apr 2017 04:00:00 GMT Elekta: New Data on Stereotactic Neurosurgery Devices Presented at AANS http://eyewiretoday.com/view.asp?url=elekta-new-data-on-stereotactic-neurosurgery-devices-presented-at-aans Elekta's Leksell Gamma Knife® radiosurgery system has been highlighted in more than 15 scientific presentations at the American Association of Neurological Surgeons (AANS) Annual Meeting in Los Angeles, the company reports. "Stereotactic... Mon, 24 Apr 2017 04:00:00 GMT Stroke Hospitalization Rates and Risk Factors Increasing in Young Adults http://eyewiretoday.com/view.asp?url=stroke-hospitalization-rates-and-risk-factors-increasing-in-young-adults Rates of acute ischemic stroke are increasing in young adults, new findings suggest (JAMA Neurology, April 10). Investigators analyzed stroke hospitalization rates as well as associated risk factors among patients between the ages of 18 and 64 years ... Mon, 17 Apr 2017 04:00:00 GMT New Evidence Suggests Potential for Blood-Based Alzheimer’s Biomarker http://eyewiretoday.com/view.asp?url=new-evidence-suggests-potential-for-blood-based-alzheimers-biomarker Plasma neurofilament light (NFL) may represent a blood-based, non-invasive biomarker in Alzheimer’s disease (AD), according to new findings published in the JAMA Neurology (March 27, 2017). In a prospective case-control study, investigators use... Tue, 28 Mar 2017 04:00:00 GMT Review Identifies Antidepressants and AEDs Effective for Nerve Pain http://eyewiretoday.com/view.asp?url=review-identifies-antidepressants-and-aeds-effective-for-nerve-pain A federal health agency has found certain antidepressants and anti-seizure drugs are among medications that effectively treat diabetic nerve pain. In findings published in the journal Neurology, researchers found moderate evidence in studies and syst... Fri, 24 Mar 2017 04:00:00 GMT ISC 2017: Exercise Significantly Improves Cognitive Impairment After Stroke http://eyewiretoday.com/view.asp?url=isc-2017-exercise-significantly-improves-cognitive-impairment-after-stroke New research presented at the ongoing International Stroke Conference 2017 suggests that structured exercise training can significantly improve brain function in stroke survivors. Given the prevalence of cognitive impairments after stroke, researcher... Thu, 23 Feb 2017 04:00:00 GMT ISC 2017: Integrative Aspiration System Compares Favorably to Stent Retrievers as Frontline Thrombectomy Therapy for Acute Stroke http://eyewiretoday.com/view.asp?url=isc-2017-integrative-aspiration-system-compares-favorably-to-stent-retrievers-as-frontline-thrombectomy-therapy-for-acute-stroke New research presented at the ongoing International Stroke Conference in Houston suggests that the ADAPT (A Direct Aspiration, First Pass Technique) compares favorably to the use of stent retrievers as an effective frontline thrombectomy approach. Da... Thu, 23 Feb 2017 04:00:00 GMT ISC 2017: STRATIS Registry Re-Affirms Benefits of Mechanical Thrombectomy from Pivotal Acute Ischemic Stroke Trials http://eyewiretoday.com/view.asp?url=isc-2017-stratis-registry-results-re-affirm-benefits-of-mechanical-thrombectomy-from-pivotal-acute-ischemic-stroke-trials Late-breaking results from the STRATIS (Systematic Evaluation of Patients Treated with Neurothrombectomy Devices for Acute Ischemic Stroke) registry re-affirm the benefits of mechanical thrombectomy that have been demonstrated in the four pivotal tri... Thu, 23 Feb 2017 04:00:00 GMT Blood Biomarker for Quick and Accurate Prognosis of MS Identified http://eyewiretoday.com/view.asp?url=blood-biomarker-for-quick-and-accurate-prognosis-of-ms-identified A newly discovered blood biomarker may aid physicians in identifying the type of multiple sclerosis (MS) in their patients. In a study recently published in Scientific Reports, investigators evaluated the links between inflammation, the kynurenine pa... Tue, 7 Feb 2017 04:00:00 GMT Investigational Narcolepsy Agent Found Effective for Severely Affected Patients with Cataplexy in Phase 3 Study http://eyewiretoday.com/view.asp?url=investigational-narcolepsy-agent-found-effective-for-several-affected-patients-with-cataplexy-in-phase-3-study Results from a phase 3 controlled trial show that pitolisant (Wakix, Bioproject Pharma) may be efficacious in severely affected narcoleptic patients with cataplexy. Pitolisant is a highly-selective histamine H3 receptor inverse agonist/antagonist tha... Thu, 26 Jan 2017 04:00:00 GMT Validation Study for Potential CTE Detection Blood Test Initiated http://eyewiretoday.com/view.asp?url=validation-study-for-potential-cte-detection-blood-test-initiated Researchers with Exosome Sciences, Inc., are initiating a clinical study involving retired NFL players and a data-supported biomarker candidate to detect and monitor Chronic Traumatic Encephalopathy (CTE) in living individuals. The study is aimed at ... Wed, 25 Jan 2017 04:00:00 GMT Lower Vitamin D Levels in Men Linked to Increased Frequency of Headache http://eyewiretoday.com/view.asp?url=decreased-vitamin-d-levels-linked-to-increased-frequency-of-headache-in-men Low levels of vitamin D was associated with markedly higher risk of frequent headache in men, according to new findings published in Scientific Reports (Article number: 39697, 2017). Investigating the associations between serum 25-hydroxyvitaminD [25... Thu, 19 Jan 2017 04:00:00 GMT High Levels of Aluminum Found in Brain Tissue of Individuals with Familial Alzheimer’s Disease http://eyewiretoday.com/view.asp?url=high-levels-of-aluminum-found-in-brain-tissue-of-individuals-with-familial-alzheimers-disease A British study has found extremely high levels of aluminum in the tissue of brains of individuals with familial Alzheimer’s disease. Using fluorescence microscopy to identify aluminum, investigators looked at brain tissue from 12 donors of tho... Thu, 12 Jan 2017 04:00:00 GMT Neuronix Reveals Data Suggesting Non-invasive TMS Device Improves Cognitive Performance in Alzheimer’s Disease http://eyewiretoday.com/view.asp?url=neuronix-reveals-data-suggesting-non-invasive-tms-device-improves-cognitive-performance-in-alzheimers-disease New findings suggest that an investigational device that combines transcranial magnetic stimulation (TMS) with cognitive training may improve cognitive performance in individuals with Alzheimer’s disease. The double-blind, placebo-controlled cl... Thu, 5 Jan 2017 04:00:00 GMT Newly Published Phase 3 Data Boost Efficacy Profile of Ocrevus in Primary Progressive and Relapsing MS http://eyewiretoday.com/view.asp?url=newly-published-phase-3-data-boost-efficacy-profile-of-ocrevus-in-primary-progressive-and-relapsing-ms As the FDA continues its review of the Biologics License Application (BLA) for Genentech’s Ocrevus (ocrelizumab), key phase 3 findings reviewing the agent’s safety and efficacy in relapsing and primary progressive multiple sclerosis (MS) ... Wed, 4 Jan 2017 04:00:00 GMT Phase 2 Data Finds Pimavanserin Effective and Well Tolerated in Patients with Alzheimer’s Disease Psychosis http://eyewiretoday.com/view.asp?url=phase-2-data-finds-pimavanserin-effective-and-well-tolerated-in-patients-with-alzheimers-disease-psychosis Phase 2 Data Finds Pimavanserin Effective and Well Tolerated in Patients with Alzheimer’s Disease PsychosisAcadia Pharmaceuticals has unveiled positive top-line results from its Phase 2 exploratory study (-019 Study) of pimavanserin in patients... Wed, 21 Dec 2016 04:00:00 GMT NeuroPace Unveils New Long-Term Data for Its RNS System http://eyewiretoday.com/view.asp?url=neuropace-unveils-new-long-term-data-for-its-rns-system At the recent American Epilepsy Society Annual Meeting in Houston, NeuroPace shared new long-term data for its RNS System for the treatment of partial-onset seizure. The RNS System monitors and responds to brain activity via a cranially implanted pro... Fri, 9 Dec 2016 04:00:00 GMT AES 2016: Fenfluramine Found Effective for both Dravet Syndrome and LGS http://eyewiretoday.com/view.asp?url=aes-2016-fenfluramine-found-effective-for-both-dravet-syndrome-and-lgs New poster data from Zogenix presented at the recent American Epilepsy Society’s annual meeting in Houston paints an encouraging portrait of the company’s investigational fenfluramine agent, ZX008, for the treatment of both Dravet Syndrom... Wed, 7 Dec 2016 04:00:00 GMT AES 2016: Sunovion Launching Phase 4 Study of Aptiom Using Wearable Technology to Detect Seizure Activity http://eyewiretoday.com/view.asp?url=aes-2016-sunovion-launching-phase-4-study-of-aptiom-using-wearable-technology-to-detect-seizure-activity At the recent American Epilepsy Society Annual Meeting in Houston, Sunovion revealed that will soon initiate enrollment for a Phase 4 clinical study (Study 093-701) evaluating the use of the Embrace watch by Empatica, an investigational wearable devi... Wed, 7 Dec 2016 04:00:00 GMT Genetic Mutation Tied to Risk of Early Parkinson’s Disease http://eyewiretoday.com/view.asp?url=genetic-mutation-tied-to-risk-of-early-parkinsons-disease Aging appears to alter how genetic factors contribute to the development of Parkinson’s disease, according to new research that has identified a gene that may increase risk of early onset Parkinson’s disease. Investigating the differences... Tue, 29 Nov 2016 04:00:00 GMT Saliva Test May Detect Alzheimer’s Disease http://eyewiretoday.com/view.asp?url=saliva-test-may-detect-alzheimers-disease A new saliva test developed by Aurin Bitech could serve as a diagnostic marker for Alzheimer’s disease, according to new findings published the Journal of Alzheimers Disease. The test is based on measuring the concentration of amyloid beta prot... Tue, 22 Nov 2016 04:00:00 GMT AMA Takes Policy Steps to Encourage Further CTE Research http://eyewiretoday.com/view.asp?url=ama-takes-policy-steps-to-encourage-further-cte-research The American Medical Association (AMA) has recently adopted new policies urging further research into the detection, causes, and prevention of head injuries. In particular, the policies encourage efforts to develop diagnostic tools as well as to unde... Wed, 16 Nov 2016 04:00:00 GMT